| TGA Action ID |
RC-2026-RN-00896-1 |
| Type of Product |
Medicine |
| Product Name/Description |
My Immune Cold + Flu
Batch Number: 45201
Expiry Date: Dec 2027
ARTG: 408266 (cancelled) |
| ARTG Number |
408266 |
| Action Type |
Recall |
| Action Level |
Consumer |
| Hazard Classification |
Class I |
| Reason for the Action |
Since 2019, listed medicines containing Andrographis paniculata (Andrographis) for supply in Australia have been required to carry a label warning about the risk of allergic reactions including severe reactions such as anaphylaxis.
However, despite these warnings, the TGA has continued to receive a sustained high number of reports of anaphylaxis associated with Andrographis-containing listed medicines, which are considered low-risk medicines.
Andrographis has now been removed from the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026. This means the ingredient is no longer available for use in new listed (low risk) medicines for supply in Australia.
To date, no adverse events have been reported for My Immune Cold + Flu. |
| Instructions for Customers/Users |
Distributors and retailers: - Inspect stock immediately and quarantine affected stock on hand to prevent further use. - Return affected stock on hand with the completed Customer Response Form to the details in the customer letter. - Notify any downstream commercial customers and instruct them to immediate cease supply and follow the recall instructions.
Consumers: - Consumers are advised that if they have the affected product, do not use it. - Consumers can return the product to the place of purchase, or contact 1800 203 327 or regaffairs@rnlabs.com.au to arrange the return of product for a refund. - If someone is suspected of having anaphylaxis, call for emergency medical help immediately by dialling ‘000’. |
| Action Commencement Date |
18/11/2026 |
| Responsible Entity |
|
| Contact Information |
1800 203 327 - Thera Health Customer Service |